Euromedin Announces Two New Product Acquisitions

LONDON, April 14, 2011 /PRNewswire/ -- European Medical Instruments Ltd (Euromedin) today announces the acquisition of Nogasin, for treatment against flatulence and bloating, and Lactocaps, for those suffering from lactose intolerance, from Finnish Pharmaceutical Verman. Both products are scheduled to launch in the UK later this year, followed by France and Ireland.

This comes shortly after the success of the company's first product launch, Asonor (R), a nasal spray that alleviates the main cause of snoring and associated sleep disturbance. Asonor(R) has been available online in the UK since March and can be purchased at http://www.asonor.co.uk.

Dr Jim Phillips, Chief Executive and co-founder of Euromedin said: "We are encouraged to see such positive uptake of Asonor(R) in only its first month since launch and are optimistic about the potential of our new acquisitions. Our goals at Euromedin are not only to improve patient treatment and care, but also to shake up the market dynamics through the introduction of innovative products. We are committed to filling those gaps in the market where there is a real need."

Nogasin is a convenient, simple capsule treatment which contains the digestive enzyme alpha-galactosidase. This enzyme breaks down complex carbohydrates in the intestine and helps to prevent both flatulence and bloating.

Lactocaps is a Scandinavian lactase deficiency enzyme replacement product, which will provide another treatment option to the estimated 5-20% of the population who suffer from lactose intolerance

Asonor(R) is a clinically-proven anti-snoring spray that alleviates the main cause of snoring and associated sleep disturbance. The product's pump-action delivers a gentle spray of solution via the nasal passage to lubricate the soft palate and lightly tighten the musculature of the throat, significantly reducing interference with breathing. There is also an added benefit of preventing the dry mouth that many snorers complain about in the morning.

To find out more about Asonor and to purchase the product, visit http://www.asonor.co.uk

About European Medical Instruments Ltd (Euromedin)

Euromedin was founded in 2008 with a mission to become a leading distributor of medical devices, delivering outstanding results for its customers. Its aim is to bring fresh thinking and innovative products to the medical and healthcare marketplaces across the EU, delivering the very highest levels of customer satisfaction. Euromedin is committed to improving the quality and effectiveness of medical devices available to consumers and healthcare professionals. To find out more, visit http://www.euromedin.com

About Verman

During the past few years Verman has been one of the fastest growing pharmaceutical companies in Finland, with several market leaders in their product categories. Verman operates in Northern Europe, the Baltic Countries and in Russia. For more information, visit http://www.verman.fi/index.php